Abstract
An increase in interstitial fluid is an expression of bone marrow edema (BME) and osteonecrosis (ON). The exact pathogenetic processes still remain unknown. Treatment options are mainly symptomatic with core decompression as surgical golden standard with immediate pain relief. Recently, it has been shown that intravenous iloprost can be used to achieve a reduction in BME and ON with a considerable improvement in the accompanying symptoms. The effect of intraveneously applied iloprost alone (12 patients) was studied against core decompression alone (12 patients) as well as iloprost following core decompression (12 patients). We could find a significant improvement in HHS, WOMAC score, SF-36 score and VAS 3 months and 1 year after therapeutical intervention in all treatment groups; however, statistically best results were obtained by combination. Concerning the MRI scans, we found a distinct reduction in BME in all groups again favoring the combination. Concerning ON, the results were not as promising as for BME. Intravenous prostacyclin and core decompression as monotherapy are of efficient therapeutical benefit in the treatment of BME, and the combination of both methods, however, seems to be most promising, also in the treatment of ON. Long-term results and higher number of patients are needed for final statements.
Similar content being viewed by others
References
Breitenseher MJ, Kramer J, Mayerhoefer ME, Aigner N, Hofmann S (2006) Differential diagnosis of bone marrow edema of the knee joint. Radiologe 46:46–54
Hofmann S (2005) The painful bone marrow edema syndrome of the hip joint. Wien Klin Wochenschr 117:111–120
Karantanas AH, Drakonaki E, Karachalios T, Korompilias AV, Malizos K (2008) Acute non-traumatic marrow edema syndrome in the knee: MRI findings at presentation, correlation with spinal DEXA and outcome. Eur J Radiol 67:22–33
Korompilias AV, Karantanas AH, Lykissas MG, Beris AE (2009) Bone marrow edema syndrome. Skeletal Radiol 38:425–436
Aigner N, Petje G, Schneider W, Meizer R, Wlk M, Kotsaris S, Knahr K, Landsiedl F (2005) Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost versus core decompression: an MRI-controlled study. Wien Klin Wochenschr 117:130–135
Hofmann S, Schneider W, Breitenseher M, Urban M, Plenk H Jr (2000) “Transient osteoporosis” as a special reversible form of femur head necrosis. Orthopade 29:411–419
Disch AC, Matziolis G, Perka C (2005) The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br 87:560–564
Koo KH, Ahn IO, Kim R, Song HR, Jeong ST, Na JB, Kim YS, Cho SH (1999) Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology 213:715–722
Plenk H Jr, Hofmann S, Eschberger J, Gstettner M, Kramer J, Schneider W, Engel A (1997) Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop Relat Res 334:73–84
Berger CE, Kroner AH, Minai-Pour MB, Ogris E, Engel A (2003) Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone 33:346–351
Meizer R, Radda C, Stolz G, Kotsaris S, Petje G, Krasny C, Wlk M, Mayerhofer M, Landsiedl F, Aigner N (2005) MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr 117:278–286
Calder JD, Buttery L, Revell PA, Pearse M, Polak JM (2004) Apoptosis–a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 86:1209–1213
Calder JD, Pearse MF, Revell PA (2001) The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. J Bone Joint Surg Br 83:419–422
Hofmann S, Kramer J, Plenk H (2005) Osteonecrosis of the hip in adults. Orthopade 34:171–183
Froberg PK, Braunstein EM, Buckwalter KA (1996) Osteonecrosis, transient osteoporosis, and transient bone marrow edema: current concepts. Radiol Clin N Am 34:273–291, x
Balakrishnan A, Schemitsch EH, Pearce D, McKee MD (2003) Distinguishing transient osteoporosis of the hip from avascular necrosis. Can J Surg 46:187–192
Guerra JJ, Steinberg ME (1995) Distinguishing transient osteoporosis from avascular necrosis of the hip. J Bone Joint Surg Am 77:616–624
Aigner N, Schneider W, Eberl V, Knahr K (2002) Core decompression in early stages of femoral head osteonecrosis: an MRI-controlled study. Int Orthop 26:31–35
Mont MA, Marulanda GA, Seyler TM, Plate JF, Delanois RE (2007) Core decompression and nonvascularized bone grafting for the treatment of early stage osteonecrosis of the femoral head. InstrCourse Lect 56:213–220
Apel DM, Vince KG, Kingston S (1994) Transient osteoporosis of the hip: a role for core decompression? Orthopedics 17:629–632
Hofmann S, Engel A, Neuhold A, Leder K, Kramer J, Plenk H Jr (1993) Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression. J Bone Joint Surg Br 75:210–216
Mihalko WM, Balos L, Santilli M, Mindell ER (2003) Osteonecrosis after powered core decompression. Clin Orthop Relat Res 412:77–83
Grant SM, Goa KL (1992) Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 43:889–924
Mont MA, Ragland PS, Parvizi J (2006) Surgical treatment of osteonecrosis of the hip. Instr Course Lect 55:167–172
Petje G, Radler C, Aigner N, Manner H, Kriegs-Au G, Grill F (2004) Pharmacological management of aseptic osteonecrosis in children. Expert Opin Pharmacother 5:1455–1462
Acknowledgments
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beckmann, J., Schmidt, T., Schaumburger, J. et al. Infusion, core decompression, or infusion following core decompression in the treatment of bone edema syndrome and early avascular osteonecrosis of the femoral head. Rheumatol Int 33, 1561–1565 (2013). https://doi.org/10.1007/s00296-012-2597-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2597-8